The genetically predicted high activity of UGT1A1, indicative of lower levels of circulating bilirubin, was positively associated with risk of esophageal squamous cell carcinoma (ESCC) [25], and not associated with risk of oral cancer [26]. The gene discussed is UGT1A1; the disease is esophageal squamous cell carcinoma.